AN INTERVENTIONAL PHASE 1B, RANDOMIZED, DOUBLE-BLIND, SPONSOR- OPEN, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND PHARMACODYNAMIC EFFECT OF PF-07258669 COMPARED TO PLACEBO IN OLDER PARTICIPANTS INCLUDING THOSE AT RISK OF MALNUTRITION

Registry ID

C4541011

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

PFIZER CANADA ULC

Start date

2025-08-20

Completion date

2025-12-19

Last update

2025-07-18

Conditions

• ANOREXIA

Related clinical trials

• FECAL MICROBIOTA TRANSPLANTATION (FMT) TO NORMALIZE GUT MICROBIOTA, METABOLOMICS, IMMUNOLOGY, COGNITIVE AND AFFECTIVE PROCESSING IN PATIENTS SUFFERING FROM ANOREXIA NERVOSA
• EFFECTS OF ANOREXIA ON PEAK BONE MASS

View on source registry